Elizabeth A Hoge

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, USA
    CNS Neurosci Ther 18:21-7. 2012
  2. ncbi The role of anxiety sensitivity in sleep disturbance in panic disorder
    E A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 2790, USA
    J Anxiety Disord 25:536-8. 2011
  3. ncbi Oxytocin levels in social anxiety disorder
    Elizabeth A Hoge
    Department of Economics, Claremont University, Claremont, CA, USA
    CNS Neurosci Ther 14:165-70. 2008
  4. ncbi Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder
    Elizabeth A Hoge
    Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
    CNS Spectr 13:522-7. 2008
  5. ncbi Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder
    Elizabeth A Hoge
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 194:962-6. 2006
  6. ncbi Resilience: research evidence and conceptual considerations for posttraumatic stress disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:139-52. 2007
  7. ncbi An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006
  8. ncbi Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Simches Research Building, 2nd Floor, 185 Cambridge St, Boston, MA 02114, USA
    J Clin Psychiatry 70:1563-70. 2009
  9. ncbi Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder
    Naomi M Simon
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Depress Anxiety 23:373-6. 2006
  10. ncbi Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biol Psychiatry 59:211-5. 2006

Collaborators

Detail Information

Publications18

  1. ncbi Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, USA
    CNS Neurosci Ther 18:21-7. 2012
    ..Previous studies have attempted to use pharmaceutical agents, especially the ?-adrenergic blocker propranolol, to reduce this overconsolidation...
  2. ncbi The role of anxiety sensitivity in sleep disturbance in panic disorder
    E A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 2790, USA
    J Anxiety Disord 25:536-8. 2011
    ..Our data suggest that sleep disturbance, and in particular sleep latency, in PD may be partly due to high levels of AS, which can be targeted with cognitive-behavioral therapeutic strategies...
  3. ncbi Oxytocin levels in social anxiety disorder
    Elizabeth A Hoge
    Department of Economics, Claremont University, Claremont, CA, USA
    CNS Neurosci Ther 14:165-70. 2008
    ..These findings may suggest a possible role for oxytocin as a facilitator of social behavior, an effect which may not be fully utilized in individuals with severe social anxiety...
  4. ncbi Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder
    Elizabeth A Hoge
    Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
    CNS Spectr 13:522-7. 2008
    ..Individuals with anxiety disorders often remain symptomatic despite treatment with a first-line pharmacologic agent. More research examining pharmacotherapy augmentation strategies to improve outcomes is needed...
  5. ncbi Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder
    Elizabeth A Hoge
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Nerv Ment Dis 194:962-6. 2006
    ..Possible explanations include differences in cultural traditions of describing distress and the mind-body dichotomy...
  6. ncbi Resilience: research evidence and conceptual considerations for posttraumatic stress disorder
    Elizabeth A Hoge
    Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Depress Anxiety 24:139-52. 2007
    ....
  7. ncbi An open-label trial of risperidone augmentation for refractory anxiety disorders
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
    J Clin Psychiatry 67:381-5. 2006
    ..There is a paucity of data to support "next-step" treatments for the many patients with anxiety disorders who remain symptomatic after initial pharmacotherapy...
  8. ncbi Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Simches Research Building, 2nd Floor, 185 Cambridge St, Boston, MA 02114, USA
    J Clin Psychiatry 70:1563-70. 2009
    ..More data are needed to guide next-step interventions for panic disorder refractory to initial intervention...
  9. ncbi Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder
    Naomi M Simon
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
    Depress Anxiety 23:373-6. 2006
    ..Larger placebo-controlled trials are needed to more definitively examine gender and treatment response in anxiety disorders...
  10. ncbi Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
    Biol Psychiatry 59:211-5. 2006
    ..We present one of the first randomized controlled trials for refractory GAD, comprising double blind augmentation with olanzapine or placebo for patients remaining symptomatic on fluoxetine...
  11. ncbi Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings
    Naomi M Simon
    Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    Psychopharmacology (Berl) 197:675-81. 2008
    ..More data are needed to guide "next step" strategies for patients with generalized anxiety disorder (GAD) remaining symptomatic despite initial pharmacotherapy...
  12. ncbi Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial
    Mark H Pollack
    Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Square, Sixth Floor, Boston, MA 02114, USA
    J Clin Psychiatry 72:892-7. 2011
    ..We present the first prospective, randomized, double-blind, placebo-controlled trial of a non-benzodiazepine hypnotic agent for the treatment of PTSD and associated insomnia...
  13. ncbi Open-label support for duloxetine for the treatment of panic disorder
    Naomi M Simon
    Department of Psychiatry, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
    CNS Neurosci Ther 15:19-23. 2009
    ....
  14. ncbi An open-label study of levetiracetam for the treatment of social anxiety disorder
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    J Clin Psychiatry 65:1219-22. 2004
    ..02) scores. CONCLUSIONS: This pilot study supports the safety and potential efficacy of a novel agent, levetiracetam, for the treatment of social anxiety disorder. Larger controlled trials are warranted to confirm these results...
  15. ncbi Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study
    Naomi M Simon
    Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, WACC 815, Boston, MA 02114, USA
    Psychosomatics 46:334-9. 2005
    ..The data add to the literature suggesting a role for selective serotonin reuptake inhibitors in the treatment of dizziness and anxiety...
  16. ncbi A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder
    Karleyton C Evans
    Department of Psychiatry, Psychiatric Neuroscience Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
    Neuropsychopharmacology 34:390-8. 2009
    ..Given the pharmacological profile of tiagabine, these findings suggest that its therapeutic effects in gSAD may be mediated by GABAergic modulation within the vmPFC...
  17. ncbi Stress reduction correlates with structural changes in the amygdala
    Britta K Hölzel
    Massachusetts General Hospital, Charlestown, MA 02129, USA
    Soc Cogn Affect Neurosci 5:11-7. 2010
    ....
  18. ncbi Nest making and oxytocin comparably promote wound healing in isolation reared rats
    Antonia Vitalo
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    PLoS ONE 4:e5523. 2009
    ....